APA (7th ed.) Citation

Moldt, B., Rakasz, E. G., Schultz, N., Chan-Hui, P., Swiderek, K., Watkins, D. I., . . . Poignard, P. (2012). MAb PGT121 protects against mucosal SHIV challenge in macaques at concentrations corresponding to its highly potent in vitro neutralization capacity. Retrovirology, 9(Suppl 2), 1. https://doi.org/10.1186/1742-4690-9-S2-O5

Chicago Style (17th ed.) Citation

Moldt, B., E. G. Rakasz, N. Schultz, P. Chan-Hui, K. Swiderek, D. I. Watkins, D. R. Burton, and P. Poignard. "MAb PGT121 Protects Against Mucosal SHIV Challenge in Macaques at Concentrations Corresponding to Its Highly Potent in Vitro Neutralization Capacity." Retrovirology 9, no. Suppl 2 (2012): 1. https://doi.org/10.1186/1742-4690-9-S2-O5.

MLA (9th ed.) Citation

Moldt, B., et al. "MAb PGT121 Protects Against Mucosal SHIV Challenge in Macaques at Concentrations Corresponding to Its Highly Potent in Vitro Neutralization Capacity." Retrovirology, vol. 9, no. Suppl 2, 2012, p. 1, https://doi.org/10.1186/1742-4690-9-S2-O5.